{
  "docId": "019de076-39d2-7099-ad19-065ffc77ed59",
  "docSlug": "e110bee9f1b318f547399ddf66ee5ee3",
  "documentTitle": "Exscientia | Results Presentation Deck | 24 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 24,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "roadmap",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The chart uses a horizontal bar format to represent development stages.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-39d2-7099-ad19-065ffc77ed59/5",
  "deckHref": "/decks/019de076-39d2-7099-ad19-065ffc77ed59",
  "deckJsonHref": "/decks/019de076-39d2-7099-ad19-065ffc77ed59.json",
  "deckAnchorHref": "/decks/019de076-39d2-7099-ad19-065ffc77ed59#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.45,
        "w": 0.96,
        "x": 0.02,
        "y": 0.235
      },
      "kind": "chart",
      "text": "Pipeline status chart",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1810f7e5-0e64-4f6d-a823-6a87ef1588ee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.26,
        "x": 0.37,
        "y": 0.76
      },
      "kind": "paragraph",
      "text": "Broad internal focus on precision oncology",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "59249d31-ffd7-4779-b192-75ef606c69d0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.3,
        "x": 0.04,
        "y": 0.76
      },
      "kind": "paragraph",
      "text": "Multi-target collaborations with Sanofi, BMS & Merck KGaA",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5a858258-cf15-4dca-a9e6-46e6d7a122a7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.28,
        "x": 0.68,
        "y": 0.76
      },
      "kind": "paragraph",
      "text": "Additional clinical programmes through DSP collaboration",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b8a45306-7abb-4b20-b3c9-ddacfedb2e25",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.8,
        "x": 0.07,
        "y": 0.945
      },
      "kind": "source-note",
      "text": "1) Phase 3 may not be required if Phase 2 is registrational; PKC-theta is in a Phase 1 healthy volunteer (HV) study; AML = acute myeloid leukaemia; SCLC = small-cell lung cancer",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "11b2d38c-d803-4447-a51e-a31733d6d446",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.55,
        "x": 0.07,
        "y": 0.13
      },
      "kind": "title",
      "text": "Internal pipeline focused on high value oncology targets",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a694c6dd-19cd-4044-9178-d8e286932b25",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.07,
        "y": 0.06
      },
      "kind": "title",
      "text": "Pipeline advancing to the clinic",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1cb99c9e-46f7-489d-ae99-8725bcb8f598",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "36e0bb0d-fad9-4aa2-8c27-e73c455b805c",
      "evidence": "Horizontal bars representing project stages over time/phases",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 15,
      "from": 4,
      "beatId": "7d3d7752-d9ec-4ba0-921e-c4049dd71ceb",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Evidence",
      "beatSlug": "evidence",
      "evidence": "The document presents various evidence, including data and results, to support its claims and pipeline advancement",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 4,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "8341406f-e753-49e5-aaa2-5cfaa5dad183",
      "evidence": "The document presents a logical chain of events, from the platform to pipeline advancement",
      "position": 0,
      "objective": "How does Exscientia's AI-driven platform drive pipeline advancement",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.7,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}